文献速递肝病消化道肿瘤与早癌

抑制硫氧还蛋白还原酶1诱导氧化应激是肝细胞癌的有效治疗策略

Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2019-03-21

研究显示肝细胞癌中硫氧还蛋白还原酶1(TXNRD1)显著过表达并与不良临床病理特征及生存相关,其通过核因子E2相关因子2转录激活对抗细胞内活性氧。遗传抑制或药物抑制剂金诺芬(AUR)抑制TXNRD1可阻碍肝癌细胞增殖、诱导凋亡并抑制体内肿瘤生长,且AUR使肝癌细胞对索拉非尼敏感。

要点

  • 人肝细胞癌样本中TXNRD1显著过表达,与更差的临床病理特征和患者生存显著相关。
  • 遗传抑制TXNRD1可阻碍肝癌细胞增殖并在体外诱导凋亡。
  • 药物抑制剂金诺芬(AUR)有效抑制体内肝细胞癌肿瘤生长,并使肝癌细胞对索拉非尼敏感。

核心结论

  • 肝细胞癌细胞依赖抗氧化系统维持氧化还原稳态和生长优势,靶向TXNRD1导致活性氧大量积累,是抑制肝细胞癌肿瘤生长的有效途径。

研究设计与样本

  • 研究采用人肝细胞癌样本转录组测序、体外细胞实验及体内肿瘤模型(流体动力学尾静脉注射模型和原位植入模型)。

主要发现

  • 人肝细胞癌样本转录组测序显示TXNRD1显著过表达,且与更差的临床病理特征和患者生存显著相关。
  • TXNRD1由核因子E2相关因子2转录激活驱动,对抗人肝细胞癌中产生的细胞内活性氧。
  • 遗传抑制TXNRD1可阻碍肝癌细胞增殖并在体外诱导凋亡。
  • 给予药理学TXNRD1抑制剂金诺芬(AUR)有效抑制体内流体动力学尾静脉注射模型和原位植入模型诱导的肝细胞癌肿瘤生长。
  • AUR使肝细胞癌细胞对传统治疗药物索拉非尼敏感。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal cancers worldwide which lacks effective treatment. Cancer cells experience high levels of oxidative stress due to increased generation of reactive oxygen species (ROS). Increased antioxidant-producing capacity is therefore found in cancer cells to counteract oxidative stress. The thioredoxin system is a ubiquitous mammalian antioxidant system which scavenges ROS, and we demonstrate that it is vital for HCC growth as it maintains intracellular reduction-oxidation (redox) homeostasis. Transcriptome sequencing in human HCC samples revealed significant overexpression of thioredoxin reductase 1 (TXNRD1), the cytosolic subunit and key enzyme of the thioredoxin system, with significant correlations to poorer clinicopathological features and patient survival. Driven by the transcriptional activation of nuclear factor (erythroid-derived 2)-like 2, the master protector against oxidative stress, TXNRD1 counteracts intracellular ROS produced in human HCC. Inhibition of TXNRD1 through genetic inhibition hindered the proliferation of HCC cells and induced apoptosis in vitro. Administration of the pharmacological TXNRD1 inhibitor auranofin (AUR) effectively suppressed the growth of HCC tumors induced using the hydrodynamic tail vein injection and orthotopic implantation models in vivo. Furthermore, AUR sensitized HCC cells toward the conventional therapeutic sorafenib. Conclusion: Our study highlights the reliance of HCC cells on antioxidants for redox homeostasis and growth advantage; targeting TXNRD1 resulted in dramatic accumulation of ROS, which was found to be an effective approach for the suppression of HCC tumor growth.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lee D, Xu IM, Chiu DK, et al. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30561826. doi:10.1002/hep.30467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。